The Preventive Vaccines Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Preventive Vaccines Market?
The market size for preventive vaccines has seen considerable growth recently. It is projected to increase from $75.94 billion in 2024 to $81.39 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Preventive Vaccines Industry?
The Preventive Vaccines Global Market is predicted to reach a size of $106.47 billion in 2029, with a compound annual growth rate (CAGR) of 6.9%.
Download Your Free Sample of the 2025 Preventive Vaccines Market Report and Uncover Key Trends Now!
Global Market Segmentation: Identifying Major Preventive Vaccines Industry Segments
The preventive vaccines market covered in this report is segmented –
1) By Type: Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines
2) By Disease Type: Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Rubella, Other Disease Types
3) By Age Group: Pediatric, Adult, Geriatric
4) By Distribution Channel: Hospitals, Clinics, Pharmacies, Other Distribution Channels
What are the Key Growth Drivers Fueling the Preventive Vaccines Market?
The key drivers in the preventive vaccines marketare:
• Increasing investment in vaccine research
• Rising prevalence of infectious diseases
• Growing demand for personalized vaccines
• Rising adoption of advanced vaccine technologies
Pre-order the 2025 Preventive Vaccines Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Preventive Vaccines Market?
The key trends in the preventive vaccines market are:
• Advancements in mRNA vaccine technology are shaping the future of the preventive vaccines market.
• Development of advanced delivery systems is another significant trend in this market.
• There is rising innovation in nanoparticle-based vaccines in the sector.
• The integration of artificial intelligence in vaccine research is increasingly influencing the future of the preventive vaccines market.
Who Are the Top Competitors & Leading Players in the Preventive Vaccines Market?
Major companies in the preventive vaccines market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• F. Hoffmann-La Roche Ltd.
• Sanofi Pasteur SA
• AstraZeneca plc
• GlaxoSmithKline plc (GSK)
• Takeda Pharmaceutical Company Limited
• Moderna Inc.
• CSL Limited
• Novavax Inc.
• Emergent BioSolutions Inc.
• Dynavax Technologies Corporation
• Serum Institute of India Pvt. Ltd.
• Vaxcyte Inc.
• Bavarian Nordic A/S
• Valneva SE
• Panacea Biotec Ltd.
• Inovio Pharmaceuticals Inc.
• Mitsubishi Tanabe Pharma Corporation
• Afrigen Biologics and Vaccines (Pty) Ltd.
Regional Dominance: Which Area Leads the Global Preventive Vaccines Market?
North America was the largest region in the preventive vaccines market in 2024
